enfuvirtide, T-20 (Fuzeon)
Type of Drug: Fusion Inhibitor
Fusion inhibitors work by stopping the HIV virus from getting into your body's healthy cells in the first place.
Approved adult dosing
90 mg (in 1 mL solution) injection
one injection under the skin, two times a day
Notes on taking this medication
- One vial contains a white powder, which is the medication (Fuzeon); another vial contains sterile water; withdraw the water with a syringe and mix into the vial with the Fuzeon
- You can prepare both doses at the same time, but should store the second vial in a refrigerator for use later on the same day
- Keep uncapped vial tops, syringes, and your hands clean while preparing Fuzeon
- Draw Fuzeon solution into the syringe only when you are ready to inject
- Rotate injection sites for each injection
- Never inject Fuzeon into a vein or muscle
- At injection site: redness; pain or tenderness; swelling; bumps; hardening of skin
- Very rare serious allergic reactions: symptoms include trouble breathing; fever with vomiting and rash; swollen feet
SOURCE: United States Department of Veterans Affairs. "Drug Dosing Toolkit, Fuzeon (enfuvirtide, T-20)."
Quick GuideHIV AIDS Facts: Symptoms and Treatments
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.